M. Rogozin´ska-Szymczak, J. Mlynarski
FULL PAPER
crude product was purified by column chromatography on silica
gel (hexane/ethyl acetate) to give the pure product. The enantio-
meric excess of the products was determined by HPLC using a
chiral stationary phase.
(t, JH,H = 7.3 Hz, 1.2 H), 0.81 (t, JH,H = 7.1 Hz, 1.8 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 203.3, 203.1, 136.8, 136.2, 129.1,
129.1, 128.2, 128.2, 128.1, 128.0, 78.4, 77.9, 53.8, 53.3, 44.5, 43.2,
29.6, 29.5, 20.3, 19.8, 13.9, 13.9 ppm. MS (EI): m/z (%) = 235 (2)
[M]+, 145 (77), 131 (15), 117 (49), 104 (86), 91 (100), 78 (26), 55
(21), 41 (27). HRMS (EI): calcd. for C13H17NO3 [M]+ 235.1208;
found 235.1208.
2,2-Dimethyl-4-nitro-3-phenylbutanal (3a):[12] The compound was
isolated as a colourless to pale yellow liquid. The enantiomeric ex-
cess was determined by HPLC analysis of the purified product with
a Daicel OD-H column [hexane/iPrOH (4:1), 1.0 mLmin–1, λ =
220 nm]: tR = 13.7 min (minor), tR = 20.2 min (major). Data for
sample with ee = 90% (S): [α]2D6 = –4.7 (c = 1.1, CHCl3) [ref.[7b]
2-(2-Nitro-1-phenylethyl)decanal (3e): The compound was isolated
as a pale oil. The enantiomeric excess was determined by HPLC
analysis of the purified product with a Daicel OD-H column [hex-
ane/iPrOH (4:1), 0.2 mLmin–1, λ = 254 nm]: tR = 47.5 min (major,
syn), tR = 50.5 min (major, anti), tR = 58.9 min (minor, syn) and tR
[α]2D6 = –4.9 (c = 1.0, CHCl ), ee = 98% (S)]. IR (film, CH Cl ): ν
˜
3
2
2
= 2962, 2919, 2849, 1724, 1553, 1378, 881, 704 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 9.53 (s, 1 H), 7.35–7.27 (m, 3 H), 7.20–
7.18 (m, 2 H), 4.85 (dd, JH,H = 13.1, 11.2 Hz, 1 H), 4.69 (dd, JH,H
= 13.1, 4.2 Hz, 1 H), 3.78 (dd, JH,H = 11.2, 4.2 Hz, 1 H), 1.13 (s,
3 H), 1.01 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 204.2,
135.4, 129.1, 128.7, 128.1, 76.3, 48.5, 48.2, 21.7, 18.9 ppm. MS (EI):
m/z (%) = 221 (0.5) [M]+, 145 (25), 131 (11), 117 (12), 104 (100),
91 (60), 77 (16), 72 (22), 43 (23). HRMS (EI): calcd. for C12H15NO3
[M]+ 221.1052; found 221.1048.
= 79.7 min (minor, anti). IR (film, CH Cl ): ν = 2953, 2926, 2855,
˜
2
2
1
1724, 1555, 1455, 1379, 701 cm–1. H NMR (400 MHz, CDCl3): δ
= 9.71 (d, JH,H = 2.8 Hz, 0.6 H), 9.48 (d, JH,H = 3.0 Hz, 0.4 H),
7.38–7.27 (m, 3 H), 7.17 (dd, JH,H = 8.1, 1.2 Hz, 2 H), 4.86–4.59
(m, 2 H), 3.84–3.73 (m, 1 H), 2.74–2.57 (m, 1 H), 1.74–1.42 (m, 2
H), 1.35–1.07 (m, 12 H), 0.87 (dt, JH,H = 8.5, 6.9 Hz, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 203.3, 203.2, 136.8, 136.3, 129.1,
129.1, 128.2, 128.2, 128.1, 128.0, 78.4, 77.9, 53.9, 53.5, 44.5, 43.2,
31.8, 31.7, 29.5, 29.4, 29.2, 29.1, 29.1, 29.0, 27.5, 27.3, 27.0, 26.4,
22.6, 22.6, 14.0, 14.0 ppm. MS (EI): m/z (%) = 305 (2) [M]+, 258
(8), 162 (27), 145 (95), 131 (41), 117 (57), 104 (100), 91 (93), 78
(18), 69 (23), 55 (34), 41 (43). HRMS (EI): calcd. for C18H27NO3
[M]+ 305.1991; found 305.1982.
2,2-Diethyl-4-nitro-3-phenylbutanal (3b): The compound was iso-
lated as a colourless oil. The enantiomeric excess was determined
by HPLC analysis of the purified product with a Daicel OD-H
column [hexane/iPrOH (97:3), 0.5 mLmin–1, λ = 220 nm]: tR
=
32.1 min (minor), tR = 34.6 min (major). Data for sample with ee
= 94% (S): [α]2D4 = +7.7 (c = 1.0, CHCl ). IR (film, CH Cl ): ν =
4-Nitro-2,3-diphenylbutanal (3f):[15,16] The compound was isolated
as a white solid. The enantiomeric excess was determined by HPLC
analysis of the purified product with a Daicel OD-H column [hex-
ane/iPrOH (98:2), 0.8 mLmin–1, λ = 208 nm]: tR = 27.3 min (major,
anti), tR = 30.3 min (minor, syn), tR = 33.9 min (major, syn) and tR
˜
3
2
2
2969, 2942, 2882, 1719, 1556, 1455, 1379, 704 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 9.58 (s, 1 H), 7.40–7.27 (m, 3 H), 7.15–
7.12 (m, 2 H), 4.88–4.78 (m, 2 H), 3.70 (dd, JH,H = 9.8, 5.8 Hz, 1
H), 1.79–1.49 (m, 4 H), 0.92 (t, JH,H = 7.5 Hz, 3 H), 0.89 (t, JH,H
= 7.5 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 207.6,
135.6, 129.1, 128.7, 128.1, 76.9, 53.3, 48.1, 23.5, 22.7, 7.9, 7.5 ppm.
MS (EI): m/z (%) = 249 (3) [M]+, 173 (20), 150 (15), 131 (33), 117
(26), 104 (100), 100 (80), 91 (73), 85 (13), 77 (20), 71 (26), 57 (30),
43 (52). HRMS (EI): calcd. for C14H19NO3 [M]+ 249.1365; found
249.1374.
= 36.5 min (minor, anti). IR (KBr): ν = 3406 (br), 3026, 2861, 1712,
˜
1
1546, 1382, 758, 702, 559 cm–1. H NMR (400 MHz, CDCl3): δ =
9.56 (d, JH,H = 2.1 Hz, 1 H), 7.46–7.25 (m, 10 H), 4.49 (dd, JH,H
= 12.8, 10.2 Hz, 1 H), 4.40 (dd, JH,H = 12.8, 4.4 Hz, 1 H), 4.30 (dt,
JH,H = 10.2, 4.4 Hz, 1 H), 4.07 (dd, JH,H = 10.2, 2.1 Hz, 1 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 196.7, 137.0, 132.4, 129.8, 129.4,
129.1, 128.9, 128.2, 128.1, 78.4, 61.7, 44.4 ppm. MS (EI): m/z (%)
= 269 (13) [M]+, 193 (23), 178 (15), 120 (100), 115 (30), 104 (97),
91 (86), 78 (17), 65 (16). HRMS (EI): calcd. for C16H15NO3 [M]+
269.1052; found 269.1054.
2-Methyl-2-(2-nitro-1-phenylethyl)pentanal (3c):[7b] The compound
was isolated as a colourless oil. The enantiomeric excess was deter-
mined by HPLC analysis of the purified product with a Daicel OJ-
H column [hexane/iPrOH (9:1), 0.8 mLmin–1, λ = 254 nm]: tR
=
29.4 min (major, syn), tR = 32.7 min (minor, anti), tR = 38.3 min
Supporting Information (see footnote on the first page of this arti-
1
cle): H and 13C NMR spectra of reaction products.
(major, anti) and tR = 46.7 min (minor, syn). IR (film, CH Cl ): ν =
˜
2
1
2
2963, 2935, 2873, 1723, 1555, 1456, 1379, 751, 705 cm–1. H NMR
(400 MHz, CDCl3): δ = 9.54 (s, 0.8 H), 9.52 (s, 0.2 H), 7.37–7.27
Acknowledgments
(m, 3 H), 7.22–7.15 (m, 2 H), 4.90–4.71 (m, 1 H), 4.63 (dd, JH,H
=
13.0, 3.9 Hz, 1 H), 3.80–3.75 (m, 1 H), 1.56–1.41 (m, 1 H), 1.29–
1.16 (m, 3 H), 1.11 (s, 2.4 H), 1.10 (s, 0.6 H), 0.92–0.82 (m, 3 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 205.3, 135.4, 129.2, 128.7,
128.1, 77.2, 51.6, 47.7, 37.6, 17.0, 15.9, 14.5 ppm. MS (EI): m/z (%)
= 249 (0.4) [M]+, 203 (7), 173 (11), 159 (13), 150 (14), 131 (34), 104
(100), 100 (74), 91 (69), 77 (13), 71 (32), 43 (38). HRMS (EI): calcd.
for C14H19NO3 [M]+ 249.1365; found 249.1369.
This project was operated with funding from the Polish National
Science Centre (grant number NCN 2011/03/B/ST5/03126). Finan-
cial support from the European Social Fund cofinanced with the
European Union funds is gratefully acknowledged.
[1] a) P. I. Dalko, Enantioselective Organocatalysis: Reactions and
Experimental Procedures, Wiley-VCH, 2007; b) A. Berkessel,
H. Groger, Asymmetric Organocatalysis: From Biomimetic Con-
cepts to Applications in Asymmetric Synthesis Wiley-VCH,
Weinheim, Germany, 2005; c) S. Bertelsenand, K. A.
Jørgensen, Chem. Soc. Rev. 2009, 38, 2178; d) P. Melchiorre,
M. Marigo, A. Carlone, G. Bartoli, Angew. Chem. Int. Ed.
2008, 47, 6138; Angew. Chem. 2008, 120, 6232; e) A. Dondoni,
A. Massi, Angew. Chem. Int. Ed. 2008, 47, 4638; Angew. Chem.
2008, 120, 4716; f) C. F. Barbas III, Angew. Chem. Int. Ed.
2008, 47, 42; Angew. Chem. 2008, 120, 44; g) H. Pellissier, Tet-
rahedron 2007, 63, 9267; h) A. Erkkila, I. Majander, P. M.
2-(2-Nitro-1-phenylethyl)pentanal (3d):[15] The compound was iso-
lated as a pale yellow oil. The enantiomeric excess was determined
by HPLC analysis of the purified product with a Daicel OD-H
column [hexane/iPrOH (9:1), 0.8 mLmin–1, λ = 208 nm]: tR
=
23.4 min (major, syn), tR = 25.5 min (major, anti), tR = 28.3 min
(minor, syn) and tR = 38.9 min (minor, anti). IR (film, CH Cl ): ν =
˜
2
2
2961, 2933, 2873, 1721, 1554, 1380, 702 cm–1. 1H NMR (400 MHz,
CDCl3): δ = 9.71 (d, JH,H = 2.8 Hz, 0.6 H), 9.48 (d, JH,H = 3.0 Hz,
0.4 H), 7.37–7.28 (m, 3 H), 7.21–7.12 (m, 2 H), 4.83–4.62 (m, 2 H),
3.81–3.75 (m, 1 H), 2.74–2.60 (m, 1 H), 1.75–1.11 (m, 4 H), 0.93
6050
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 6047–6051